Wyeth to launch "Tygacil" in India

Wyeth Ltd has announced that the Company is launching "Tygacil" in India on June 22, 2007.

Tygacil(Tigecycline) is a novel intravenous antibiotic with a broad spectrum of ant microbial activity against drug - resistant bacteria. It is the first antibiotic in a new class called glycylcycline. Tygacil is indicated for the treatment of complicated skin and skin structure infections and intra - abdominal infections.

The stock closed the day at Rs.551, up by Rs.0.95 or 0.17%. The stock hit an intraday high of Rs.555 and low of Rs.542.15. The total traded quantity was 2772 compared to 2 week average of 36454.

Source : Equity Bulls

Keywords